Efficacy of pentoxifylline in prevention of contrast-induced nephropathy in angioplasty patients

International Urology and Nephrology

Volumn 44, Issue 4, 2012, Pages 1145-1149

  Firouzi, Ata ^a   Eshraghi, Ali ^a   Shakerian, Farshad ^a   Sanati, Hamid Reza ^a   Salehi, Negar ^a   Zahedmehr, Ali ^a   Kiani, Reza ^a   Maani, Mohsen ^a   Pedarzadeh, Ali ^a  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Angioplasty; Contrast media; Contrast induced nephropathy; Pentoxifylline

Indexed keywords

CONTRAST MEDIUM; CREATININE; PENTOXIFYLLINE;

ADULT; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PROSPECTIVE STUDY; PROTEIN DETERMINATION; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION; RISK FACTOR; SINGLE BLIND PROCEDURE; TRANSLUMINAL CORONARY ANGIOPLASTY;

ACUTE KIDNEY INJURY; ADULT; ANGIOPLASTY, BALLOON, CORONARY; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; FREE RADICAL SCAVENGERS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PENTOXIFYLLINE; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84867901181     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-011-0053-4     Document Type: Article

References (20)

1. McCullough P (2007) Renal complications of contrast media. In: King Spencer B, Alan C (eds) Interventional cardiology, Chapter 23, 1st edn. McGraw-Hill, China
2. Brar SS, Shen AY, Jorgensen MB, Kotlewski A, Aharonian VJ, Desai N, Ree M, Shah AI, Burchette RJ (2008) Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial. JAMA 300(9):1038-1046
3. Roozbeh J, Hamidian Jahromi A, Sharifian M, Pakfetrat M, Afshariani R (2008) Protective effect of pentoxifylline on contrast induced nephropathy. Saudi J Kidney Dis Transpl 19(6):985-986
4. Ferrario F, Barone MT, Landoni G, Genderini A, Heidemperger M, Trezzi M, Piccaluga E, Danna P, Scorza D (2009) Acetylcysteine and non-ionic isosmolar contrastinduced nephropathy-a randomized controlled study. Nephrol Dial Transplant 24(10):3103-3107
5. Gomes VO, Poli de Figueredo CE, Caramori P, Lasevitch R, Bodanese LC, Araújo A, Röedel AP, Caramori AP, Brito FS Jr, Bezerra HG, Nery P, Brizolara A (2005) N-acetylcysteine does not prevent contrast induced nephropathy after cardiac catheterisation with an ionic low osmolality contrast medium: a multicentre clinical trial. Heart 91(6):774-778
6. Huber W, Eckel F, Hennig M, Rosenbrock H, Wacker A, Saur D, Sennefelder A, Hennico R, Schenk C, Meining A, Schmelz R, Fritsch R, Weiss W, Hamar P, Heemann U, Schmid RM (2006) Prophylaxis of contrast materialinduced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study. Radiology 239(3):793-804
7. Amini M, Salarifar M, Amirbaigloo A, Masoudkabir F, Esfahani F (2009) N-acetylcysteine does not prevent contrast- induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial. Trials 10:45
8. Jo SH, Koo BK, Park JS, Kang HJ, Kim YJ, Kim HL, Chae IH, Choi DJ, Sohn DW, Oh BH, Park YB, Choi YS, Kim HS (2009) N-acetylcysteine versus ascorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial. Am Heart J 157(3):576-583
9. Ng TM, Shurmur SW, Silver M, Nissen LR, O'Leary EL, Rigmaiden RS, Cieciorka M, Porter LL, Ineck BA, Kline ME, Puumala SE (2006) Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN). Int J Cardiol 109(3):322-328
10. Briguori C, Colombo A, Airoldi F, Violante A, Castelli A, Balestrieri P, Paolo Elia P, Golia B, Lepore S, Riviezzo G, Scarpato P, Librera M, Focaccio A, Ricciardelli B (2004) N-acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity. J Am Coll Cardiol 44(4):762-765
11. Walker PD, Brokering KL, Theobald JC (2003) Fenoldopam and N-acetylcysteine for the prevention of radiographic contrast material-induced nephropathy: a review. Pharmacotherapy 23(12):1617-1626
12. Bagshaw SM, Ghali WA (2005) Theophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. Arch Intern Med 165(10): 1087-1093
13. Kapoor A, Kumar S, Gulati S, Gambhir S, Sethi RS, Sinha N (2002) The role of theophylline in contrast-induced nephropathy: a case-control study. Nephrol Dial Transplant 17(11):1936-1941
14. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, Bersin RM, Van Moore A, Simonton CA 3rd, Rittase RA, Norton HJ, Kennedy TP (2004) Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291(19):2328-2334
15. Kanbay M, Covic A, Coca SG, Turgut F, Akcay A, Parikh CR (2009) Sodium bicarbonate for the prevention of contrast- induced nephropathy: a meta-analysis of 17 randomized trials. Int Urol Nephrol 41(3):617-627
16. Spargias K, Alexopoulos E, Kyrzopoulos S, Iokovis P, Greenwood DC, Manginas A, Voudris V, Pavlides G, Buller CE, Kremastinos D, Cokkinos DV (2004) Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 110(18):2837-2842
17. Boscheri A, Weinbrenner C, Botzek B, Reynen K, Kuhlisch E, Strasser RH (2007) Failure of ascorbic acid to prevent contrast-media induced nephropathy in patients with renal dysfunction. Clin Nephrol 68(5):279-286
18. Abizaid AS, Clark CE, Mintz GS, Dosa S, Popma JJ, Pichard AD, Satler LF, Harvey M, Kent KM, Leon MB (1999) Effects of dopamine and aminophylline on contrastinduced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency. Am J Cardiol 83(2):260-3, A5
19. Staudinger T, Presterl E, Graninger W, Locker GJ, Knapp S, Laczika K, Klappacher G, Stoiser B, Wagner A, Tesinsky P, Kordova H, Frass M (1996) Influence of pentoxifylline on cytokine levels and inflammatory parameters in septic shock. Intensive Care Med 22(9):888-893
20. Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44(7):1393-1399